I think part of the problem with AVH is they have a new product Recel go waiting on approval from the FDA on May 30. It must be hard trying to sell the "old kit" when the Recell go might be a better option for some clinicians. They'll just wait but agreed it's a mess with AVH although I think the drop is OTT.
EYE on the other hand has a market leading product that is getting excellent feedback, their sales have been increasing fast, are clearly taking market share from their competitors & they're promoting it at the conferences. Totally different scenario IMO it's aggressive but justified.
Time will tell though !!
Nova Eye Medical (EYE) Discussion, page-2604
-
- There are more pages in this discussion • 575 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.34M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 21.0¢ | $95.62K | 444.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 52740 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 73205 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| EYE (ASX) Chart |